Anavex Life Sciences Corp (AVXL)

[Pineapple1]

Yes TomP1 that's what I am saying, the founders of the company decided to buy a shell and move over their technology, so as to fly under the radar of competitors by not trying to fund the company with an IPO. I am assuming that going through a traditional IPO process would require a lot of discussion with venture capitalists, and brokerage houses/investment banks and financial insiders that would tip off Big pharma as to what the company was focusing on. Thereby reducing the competitive edge of what 8 years or more that they have on competition. Of course some companies, (and people) are still in denial on how effect the product is, but they maybe coming around. Pfizer cut their program last October, Lilly's CTAD data blew up...Axovant should just go away.
Like said, this is the best in class, Trillion dollar market cap, maybe.